Cytotoxic edema in a patient with neuromyelitis optica: This may be suggestive of various pathogenic roles of NMO-IgG

Cytotoxic edema in a patient with neuromyelitis optica: This may be suggestive of various pathogenic roles of NMO-IgG

ग्रंथसूची विवरण
मुख्य लेखकों:	Min, J, Kim, B, Waters, P, Vincent, A, Lee, K
स्वरूप:	Conference item
प्रकाशित:	2010

समान संसाधन

NMO-IgG in the diagnosis of neuromyelitis optica.
द्वारा: Jarius, S, और अन्य
प्रकाशित: (2007)

An audit of the diagnostic usefulness of the NMO-IgG assay for neuromyelitis optica
द्वारा: Littleton, E, और अन्य
प्रकाशित: (2006)

Revised diagnostic criteria for neuromyelitis optica--incorporation of NMO-IgG status.
द्वारा: Jarius, S, और अन्य
प्रकाशित: (2007)

Devic's neuromyelitis optica: Prognostic implications of NMO IgG status in Turkish patients
द्वारा: Akman-Demir, G, और अन्य
प्रकाशित: (2008)

Frequency of Aqp4-Ab in patients with neuromyelitis optica (Devic's syndrome) is higher than predicted by NMO-IgG testing
द्वारा: Jarius, S, और अन्य
प्रकाशित: (2007)

Neuromyelitis optica IgG causes placental inflammation and fetal death.
द्वारा: Saadoun, S, और अन्य
प्रकाशित: (2013)

Neuromyelitis optica IgG causes placental inflammation and fetal death in mice
द्वारा: Saadoun, S, और अन्य
प्रकाशित: (2013)

Effect of IgG from seronegative and seropositive neuromyelitis optica patients on mouse brain
द्वारा: Saadoun, S, और अन्य
प्रकाशित: (2013)

Cerebrospinal fluid/serum gradient of IgG is associated with disability at acute attacks of neuromyelitis optica.
द्वारा: Kim, S, और अन्य
प्रकाशित: (2011)

NMO-IgG/Aqp4-Ab belongs to the IgG1 subclass and activates complement in vitro
द्वारा: Jarius, S, और अन्य
प्रकाशित: (2007)

IgG subclasses of disease-specific antibodies and complement activation in-vitro in seronegative myasthenia gravis and neuromyelitis optica
द्वारा: Jacob, S, और अन्य
प्रकाशित: (2008)

MOG-IGG IN NMO AND NMO-LIKE DISORDERS
द्वारा: Luppe, S, और अन्य
प्रकाशित: (2014)

Diagnosis of neuromyelitis optica (NMO) spectrum disorders: is MRI obsolete?
द्वारा: Downer, J, और अन्य
प्रकाशित: (2012)

Diagnosis of neuromyelitis optica (NMO) spectrum disorders: Is MRI obsolete?
द्वारा: Downer, J, और अन्य
प्रकाशित: (2012)

IgG subclasses of disease-specific antibodies and complement activation in vitro in myasthenia gravis and neuromyelitis optica
द्वारा: Jacob, S, और अन्य
प्रकाशित: (2007)

A novel sensitive assay for aqueporin-4 antibodies (NMO-IgG)
द्वारा: Waters, P, और अन्य
प्रकाशित: (2007)

Neutrophil protease inhibition reduces NMO-IgG-induced damage in mouse brain
द्वारा: Papadopoulos, M, और अन्य
प्रकाशित: (2011)

LONG TERM OUTCOME IN NEUROMYELITIS OPTICA: LESSONS FROM 6 YEARS OF THE UK NMO STUDY
द्वारा: Jacob, A, और अन्य
प्रकाशित: (2009)

Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays.
द्वारा: Waters, P, और अन्य
प्रकाशित: (2012)

Status of diagnostic approaches to AQP4-IgG seronegative NMO and NMO/MS overlap syndromes
द्वारा: Juryńczyk, M, और अन्य
प्रकाशित: (2015)

T cell deficiency does not reduce lesions in mice produced by intracerebral injection of NMO-IgG and complement.
द्वारा: Saadoun, S, और अन्य
प्रकाशित: (2011)

Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice.
द्वारा: Saadoun, S, और अन्य
प्रकाशित: (2010)

Reduced serum uric acid levels in neuromyelitis optica: serum uric acid levels are reduced during relapses in NMO.
द्वारा: Min, J, और अन्य
प्रकाशित: (2012)

Spinal cord MRI features in neuromyelitis optica (NMO): characteristics and relationship with severity and recovery in longitudinally extensive transverse myelitis (LETM) attacks
द्वारा: Murchison, A, और अन्य
प्रकाशित: (2013)

Complement activation in patients with neuromyelitis optica
द्वारा: Nytrova, P, और अन्य
प्रकाशित: (2014)

Complement activation in patients with neuromyelitis optica.
द्वारा: Nytrova, P, और अन्य
प्रकाशित: (2014)

The borderland of neuromyelitis optica.
द्वारा: Matthews, L, और अन्य
प्रकाशित: (2009)

Antibodies to aquaporin-1 are not present in neuromyelitis optica
द्वारा: Waters, P, और अन्य
प्रकाशित: (2015)

The evolving clinical spectrum of neuromyelitis optica
द्वारा: Viegas, S, और अन्य
प्रकाशित: (2008)

Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset.
द्वारा: Collongues, N, और अन्य
प्रकाशित: (2013)

Use of mitoxantrone in neuromyelitis optica.
द्वारा: Kitley, J, और अन्य
प्रकाशित: (2011)

TREATMENT OF NEUROMYELITIS OPTICA WITH AZATHIOPRINE
द्वारा: Elsone, L, और अन्य
प्रकाशित: (2012)

Symptomatic brain involvement as the initial manifestation of neuromyelitis optica.
द्वारा: Min, J, और अन्य
प्रकाशित: (2013)

Symptomatic, radiological and pathological involvement of the hypothalamus in neuromyelitis optica.
द्वारा: Viegas, S, और अन्य
प्रकाशित: (2009)

Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica.
द्वारा: Jarius, S, और अन्य
प्रकाशित: (2008)

Detection of anti-aquaporin-4 antibodies in neuromyelitis optica: current status of the assays.
द्वारा: Waters, P, और अन्य
प्रकाशित: (2008)

METHOTREXATE MAY BE AN ALTERNATIVE TO AZATHIOPRINE IN NEUROMYELITIS OPTICA WITH AQUAPORIN-4 ANTIBODIES
द्वारा: Kitley, J, और अन्य
प्रकाशित: (2012)

Deteksi IgG
द्वारा: , SUHARTI, Netti, और अन्य
प्रकाशित: (2001)

IgG4 autoantibodies and autoantigens in the context of IgG4-autoimmune disease and IgG4-related disease
द्वारा: Motta, RV, और अन्य
प्रकाशित: (2024)

Neuromyelitis optica in patients with gluten sensitivity associated with antibodies to aquaporin-4.
द्वारा: Jarius, S, और अन्य
प्रकाशित: (2008)